Gene breakthrough on lithium treatment for bipolar disorder
Genes linked to schizophrenia in psychiatric patients suffering from bipolar disorder are the reason why such patients don't respond to the "gold standard" treatment for bipolar -- the drug lithium -- according to international
research.